We are live on ! Find out more
KZIA

Kazia Therapeutics
KZIA

15 hedge funds and large institutions have $5.03M invested in Kazia Therapeutics in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

25% more funds holding

Funds holding: 12 → 15 (+3)

16% more capital invested

Capital invested by funds: $4.35M → $5.03M (+$684K)

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
2
Closed
1
Calls
$293K
Puts
–
Net Calls
+$293K
Net Calls Change
+$165K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$525K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$100K
3
Citadel Advisors
Citadel Advisors
Florida
+$47.2K
4
TCWM
Total Clarity Wealth Management
Illinois
+$46.7K
5
Wells Fargo
Wells Fargo
California
+$4.91K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$401K
2
ACM
ACT Capital Management
Pennsylvania
-$247K
3
SG Americas Securities
SG Americas Securities
New York
-$45.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$3.25M +$525K +1,068 +23%
SG Americas Securities
2
SG Americas Securities
New York
$450K -$45.2K -92 -10%
Truist Financial
3
Truist Financial
North Carolina
$329K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$283K -$401K -816 -62%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$281K +$100K +204 +71%
Citadel Advisors
6
Citadel Advisors
Florida
$202K +$47.2K +96 +38%
TW
7
Transform Wealth
Colorado
$120K – – –
TCWM
8
Total Clarity Wealth Management
Illinois
$54K +$46.7K +95 New
Simplex Trading
9
Simplex Trading
Illinois
$44K – – –
Wells Fargo
10
Wells Fargo
California
$6K +$4.91K +10 New
UBS Group
11
UBS Group
Switzerland
$5K +$3.93K +8 New
Deutsche Bank
12
Deutsche Bank
Germany
$1K – – –
SPIA
13
Steward Partners Investment Advisory
New York
$1K – – –
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$1K +$491 +1 New
RE
15
RBC Europe
United Kingdom
$362 – – –
ACM
16
ACT Capital Management
Pennsylvania
– -$247K -500 Closed

KZIA Hedge Fund Activity: Q3 2021 in Review

15 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q3 2021, worth a combined $5.03M — up 16% from $4.35M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new KZIA positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $525K. The largest seller was Renaissance Technologies, cutting an estimated $401K.

  • 15 institutional investors held Kazia Therapeutics (KZIA) as of Q3 2021, up from 12 in Q2 2021.
  • Funds reported $5.03M of Kazia Therapeutics stock for Q3 2021, up 16% quarter-over-quarter.
  • 4 funds opened new Kazia Therapeutics positions in Q3 2021 and 1 closed out, a net change of +3 holders.
  • The largest Kazia Therapeutics buyer in Q3 2021 was Morgan Stanley, an estimated $525K added.
  • The largest Kazia Therapeutics seller in Q3 2021 was Renaissance Technologies, an estimated $401K sold.

Based on aggregated 13F filings for Q3 2021.